Angiomax
Links shared publicly online about this topic
Angiomax May Get Patent Extension - NYTimes.com
prescriptions.blogs.nytimes.com — “Without an appeal by the federal government, the Medicines Company of New Jersey appears to have won a round to keep the patent on its blood-thinner drug.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on October 5, 2010 at 6:27 pm By:
Angiomax May Get Patent Extension: Without an appeal by the federal government, the Medicines Company of New Jers... http://nyti.ms/bqMjvN
Angiomax Reduced Cardiac Mortality By 41%; Reduced Overall Mortality By 25% In Severe Heart Attack Patients Following Angioplasty
medicalnewstoday.com — “The medicines company (nasdaq: mdco) today announced the presentation of 2-year clinical results from the landmark horizons-ami trial. the trial showed that patients who had suffered the most seve” View full resource at medicalnewstoday.com
Most Recently Shared on September 28, 2009 at 12:12 pm By:
MedicalNewsToday: Angiomax Reduced Cardiac Mortality By 41%; Reduced Overall Mortality By 25% http://bit.ly/1hTb6s Full http://bit.ly/eGYQp
FDA Law Blog: The Medicines Company Tosses Up a Hail Mary Pass " Sues PTO and FDA Over ANGIOMAX Patent Term Extension Decisions
fdalawblog.net — “By Kurt R. Karst " As we predicted, Massachusetts-based The Medicines Company (TMC) has sued the U.S. Patent and Trademark Office (PTO) and FDA in connection with the company's efforts to obtain a Patent Term Extension (PTE) for U.S. Patent...” View full resource at fdalawblog.net
Most Recently Shared on February 6, 2010 at 2:02 am By:
RT @IPThinkTank: Angiomax – US: The Medicines Company sues PTO and FDA over Angiomax patent term extension decisions http://bit.ly/bKCE7n
Angiomax Reduced Cardiac Mortality by 41%; Reduced Overall Mortality by 25% in Severe Heart Attack Patients Following Angioplasty - Drugs.com MedNews
drugs.com — “HORIZONS-AMI Trial Two-Year Results Presented at TCT PARSIPPANY, NJ, Sep 25, 2009 (MARKETWIRE The Medicines Company (NASDAQ MDCO) today announced the presentati” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 6:22 am By:
Tammi Jacobs Health Professional
Angiomax Reduced Cardiac Mortality by 41%; Reduced Overall ... http://bit.ly/1FOMh2
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on January 24, 2012 at 1:30 pm By:
PharmaLive Pharma and Health News
Medicines Co., APP Pharma Settle Angiomax Dispute #TherapeuticsDaily http://t.co/U4MUJebA
TCT: Last Word Positive on Trial of Bivalirudin (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The final report from the HORIZONS-AMI trial revealed an increasing mortality benefit for ST-elevation MI patients treated with bivalirudin (Angiomax) -- compared with those who received unfractioned heparin plus abciximab (ReoPro) or eptifibatide (Integrelin), according to the trial's lead investigator.” View full resource at qualitypointtech.net
Most Recently Shared on September 27, 2010 at 3:48 pm By:
TCT: Last Word Positive on Trial of Bivalirudin (CME/CE): WASHINGTON (MedPage Today) -- The final report from the ... http://bit.ly/aEZCGI
Medicines Co. of Parsippany wins patent battle | NJ.com
nj.com — “Medicines Co. won a court ruling that may provide an additional four years of patent protection on its anticoagulant drug Angiomax, which accounts for almost all company revenue. The shares rose the most since trading began. U.S. District Judge Claude Hilton in Alexandria, Virginia, said the Patent and Trademark Office misinterpreted federal law when it found that Medicines Co....” View full resource at nj.com
Most Recently Shared on August 4, 2010 at 11:25 am By:
NJ.com: Medicines Co. of Parsippany wins patent battle. http://bit.ly/9pnJLg
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Catherine K
Work in health publishing field. Passionate about healthy living.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
Advertisement
